Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Aakaar Medical Technologies Limited has informed the Exchange about Arrangements for strategic technical manufacturing or marketing tie upmore...
Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meetmore...
Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 20 2026 titled Strategic Tie-Up with Tricopat .more...
Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 18 2026 titled Strategic Tie-Up with ...more...
Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 16 2026 titled XOMAGEr Plant Exosomes Registra...more...
Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated February 13 2026 titled USFDA Approval of Sayp...more...
Aakaar Medical Technologies Limited has informed the Exchange about Product launchmore...
Aakaar Medical Technologies Limited has informed the Exchange about VM Corporation Product launchmore...
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find attached herewith the certificate i...more...
Aakaar Medical Technologies Limited has informed the Exchange regarding Resignation of Mrs. Sweta Shah as Chief Financial Officer of the company w.e....more...
Aakaar Medical Technologies Limited has informed the Exchange about Transcript of Earnings Concall dated 10.11.2025more...
Aakaar Medical Technologies Limited has informed the Exchange about Link of Audio Recording of Earnings Call held on 10.11.2025more...
Aakaar Medical Technologies Limited has informed the Exchange about Investor Presentationmore...
Aakaar Medical Technologies Limited has informed the Exchange regarding a press release dated November 10 2025 titled Aakaar Medical Technol...more...
Aakaar Medical Technologies Limited has submitted to the Exchange the financial results for the period ended September 30 2025.more...
As of September 2025 67.01% is owned by Promoters and 32.99% by Public. Among Promoters holding Indian Promoters holds 63.01% and Foreign Promoters h...more...
BOARD MEETINGS Company Name : Biogen Pharmachem Date : 23-03-2026